Human Fetal Membranes: A Source of Stem Cells for Tissue Regeneration and Repair?

Placenta

Volumn 30, Issue 1, 2009, Pages 2-10

  Ilancheran, S ^a   Moodley, Y ^a   Manuelpillai, U ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Amnion; Chorion; Fetal membranes; Multipotent; Stem cells

Indexed keywords

AMNION CELL; ARTICLE; CELL DIFFERENTIATION; CELL LINEAGE; CHORION; EMBRYONIC STEM CELL; FETUS MEMBRANE; HUMAN; IN VITRO STUDY; MESENCHYMAL STEM CELL; PLACENTA; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; STROMA CELL; TISSUE INJURY; TISSUE REGENERATION; UMBILICAL CORD;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; EMBRYONIC STEM CELLS; EPITHELIAL CELLS; EXTRAEMBRYONIC MEMBRANES; HUMANS; REGENERATION; STROMAL CELLS; WOUND HEALING;

EID: 57649200642     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.placenta.2008.09.009     Document Type: Article

References (88)

1. Shamblott M.J., Axelman J., Wang S., Bugg E.M., Littlefield J.W., Donovan P.J., et al. Derivation of pluripotent stem cells from cultured human primordial germ cells. Proc Natl Acad Sci U S A 95 (1998) 13726-13731
2. Thomson J.A., Itskovitz-Eldor J., Shapiro S.S., Waknitz M.A., Swiergiel J.J., Marshall V.S., et al. Embryonic stem cell lines derived from human blastocysts. Science 282 (1998) 1145-1147
3. Verfaillie C.M. Adult stem cells: assessing the case for pluripotency. Trends Cell Biol 12 (2002) 502-508
4. Osafune K., Caron L., Borowiak M., Martinez R.J., Fitz-Gerald C.S., Sato Y., et al. Marked differences in differentiation propensity among human embryonic stem cell lines. Nat Biotechnol 26 (2008) 313-315
5. Chen H.F., Kuo H.C., Chien C.L., Shun C.T., Yao Y.L., Ip P.L., et al. Derivation, characterization and differentiation of human embryonic stem cells: comparing serum-containing versus serum-free media and evidence of germ cell differentiation. Hum Reprod 22 (2007) 567-577
6. Harun R., Ruban L., Matin M., Draper J., Jenkins N.M., Liew G.C., et al. Cytotrophoblast stem cell lines derived from human embryonic stem cells and their capacity to mimic invasive implantation events. Hum Reprod 21 (2006) 1349-1358
7. Gerami-Naini B., Dovzhenko O.V., Durning M., Wegner F.H., Thomson J.A., and Golos T.G. Trophoblast differentiation in embryoid bodies derived from human embryonic stem cells. Endocrinology 145 (2004) 1517-1524
8. Xu R.H., Chen X., Li D.S., Li R., Addicks G.C., Glennon C., et al. BMP4 initiates human embryonic stem cell differentiation to trophoblast. Nat Biotechnol 20 (2002) 1261-1264
9. Kroon E., Martinson L.A., Kadoya K., Bang A.G., Kelly O.G., Eliazer S., et al. Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo. Nat Biotechnol 26 (2008) 443-452
10. Laflamme M.A., Chen K.Y., Naumova A.V., Muskheli V., Fugate J.A., Dupras S.K., et al. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat Biotechnol 25 (2007) 1015-1024
11. Ben-Hur T., Idelson M., Khaner H., Pera M., Reinhartz E., Itzik A., et al. Transplantation of human embryonic stem cell-derived neural progenitors improves behavioral deficit in Parkinsonian rats. Stem Cells 22 (2004) 1246-1255
12. Klimanskaya I., Rosenthal N., and Lanza R. Derive and conquer: sourcing and differentiating stem cells for therapeutic applications. Nat Rev Drug Discov 7 (2008) 131-142
13. Roy N.S., Cleren C., Singh S.K., Yang L., Beal M.F., and Goldman S.A. Functional engraftment of human ES cell-derived dopaminergic neurons enriched by coculture with telomerase-immortalized midbrain astrocytes. Nat Med 12 (2006) 1259-1268
14. Grinnemo K.H., Sylven C., Hovatta O., Dellgren G., and Corbascio M. Immunogenicity of human embryonic stem cells. Cell Tissue Res 331 (2008) 67-78
15. Li L., Baroja M.L., Majumdar A., Chadwick K., Rouleau A., Gallacher L., et al. Human embryonic stem cells possess immune-privileged properties. Stem Cells 22 (2004) 448-456
16. Drukker M. Immunogenicity of embryonic stem cells and their progeny. Meth Enzymol 420 (2006) 391-409
17. Park I.H., Lerou P.H., Zhao R., Huo H., and Daley G.Q. Generation of human-induced pluripotent stem cells. Nat Protoc 3 (2008) 1180-1186
18. Zhang X., Stojkovic P., Przyborski S., Cooke M., Armstrong L., Lako M., et al. Derivation of human embryonic stem cells from developing and arrested embryos. Stem Cells 24 (2006) 2669-2676
19. Togel F., and Westenfelder C. Adult bone marrow-derived stem cells for organ regeneration and repair. Dev Dyn 236 (2007) 3321-3331
20. Picinich S.C., Mishra P.J., Mishra P.J., Glod J., and Banerjee D. The therapeutic potential of mesenchymal stem cells. Cell- & tissue-based therapy. Expert Opin Biol Ther 7 (2007) 965-973
21. Le Blanc K. Mesenchymal stromal cells: tissue repair and immune modulation. Cytotherapy 8 (2006) 559-561
22. Bieback K., and Kluter H. Mesenchymal stromal cells from umbilical cord blood. Curr Stem Cell Res Ther 2 (2007) 310-323
23. O'Donoghue K., and Fisk N.M. Fetal stem cells. Best Pract Res Clin Obstet Gynaecol 18 (2004) 853-875
24. Mazurier F., Doedens M., Gan O.I., and Dick J.E. Characterization of cord blood hematopoietic stem cells. Ann N Y Acad Sci 996 (2003) 67-71
25. Samuel G.N., Kerridge I.H., and O'Brien T.A. Umbilical cord blood banking: public good or private benefit?. Med J Aust 188 (2008) 533-535
26. Yen B.L., Huang H.I., Chien C.C., Jui H.Y., Ko B.S., Yao M., et al. Isolation of multipotent cells from human term placenta. Stem Cells 23 (2005) 3-9
27. Fukuchi Y., Nakajima H., Sugiyama D., Hirose I., Kitamura T., and Tsuji K. Human placenta-derived cells have mesenchymal stem/progenitor cell potential. Stem Cells 22 (2004) 649-658
28. Miki T., and Strom S.C. Amnion-derived pluripotent/multipotent stem cells. Stem Cell Rev 2 (2006) 133-142
29. In 't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., Noort W.A., Claas F.H., Willemze R., et al. Amniotic fluid as a novel source of mesenchymal stem cells for therapeutic transplantation. Blood 102 (2003) 1548-1549
30. Fauza D. Amniotic fluid and placental stem cells. Best Pract Res Clin Obstet Gynaecol 18 (2004) 877-891
31. Bourne G. The foetal membranes. A review of the anatomy of normal amnion and chorion and some aspects of their function. Postgrad Med J 38 (1962) 193-201
32. Cross J.C. Formation of the placenta and extraembryonic membranes. Ann N Y Acad Sci 857 (1998) 23-32
33. Sakuragawa N., Kakinuma K., Kikuchi A., Okano H., Uchida S., Kamo I., et al. Human amnion mesenchyme cells express phenotypes of neuroglial progenitor cells. J Neurosci Res 78 (2004) 208-214
34. In 't Anker P.S., Scherjon S.A., Kleijburg-van der Keur C., de Groot-Swings G.M., Claas F.H., Fibbe W.E., et al. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta. Stem Cells 22 (2004) 1338-1345
35. Portmann-Lanz C.B., Schoeberlein A., Huber A., Sager R., Malek A., Holzgreve W., et al. Placental mesenchymal stem cells as potential autologous graft for pre- and perinatal neuroregeneration. Am J Obstet Gynecol 194 (2006) 664-673
36. Soncini M., Vertua E., Gibelli L., Zorzi F., Denegri M., Albertini A., et al. Isolation and characterization of mesenchymal cells from human fetal membranes. J Tissue Eng Regen Med 1 (2007) 296-305
37. Parolini O., Alviano F., Bagnara G.P., Bilic G., Buhring H.J., Evangelista M., et al. Concise review: isolation and characterization of cells from human term placenta: outcome of the first international workshop on placenta derived stem cells. Stem Cells 26 (2008) 300-311
38. Kim J., Kang H.M., Kim H., Kim M.R., Kwon H.C., Gye M.C., et al. Ex vivo characteristics of human amniotic membrane-derived stem cells. Cloning Stem Cells 9 (2007) 581-594
39. Pasquinelli G., Tazzari P., Ricci F., Vaselli C., Buzzi M., Conte R., et al. Ultrastructural characteristics of human mesenchymal stromal (stem) cells derived from bone marrow and term placenta. Ultrastruct Pathol 31 (2007) 23-31
40. Alviano F., Fossati V., Marchionni C., Arpinati M., Bonsi L., Franchina M., et al. Term amniotic membrane is a high throughput source for multipotent mesenchymal stem cells with the ability to differentiate into endothelial cells in vitro. BMC Dev Biol 7 (2007) 11
41. Tamagawa T., Oi S., Ishiwata I., Ishikawa H., and Nakamura Y. Differentiation of mesenchymal cells derived from human amniotic membranes into hepatocyte-like cells in vitro. Hum Cell 20 (2007) 77-84
42. Zhao P., Ise H., Hongo M., Ota M., Konishi I., and Nikaido T. Human amniotic mesenchymal cells have some characteristics of cardiomyocytes. Transplantation 79 (2005) 528-535
43. Ilancheran S., Michalska A., Peh G., Wallace E.M., Pera M., and Manuelpillai U. Stem cells derived from human fetal membranes display multilineage differentiation potential. Biol Reprod 77 (2007) 577-588
44. Miki T., Lehmann T., Cai H., Stolz D.B., and Strom S.C. Stem cell characteristics of amniotic epithelial cells. Stem Cells 23 (2005) 1549-1559
45. Terada S., Matsuura K., Enosawa S., Miki M., Hoshika A., Suzuki S., et al. Inducing proliferation of human amniotic epithelial (HAE) cells for cell therapy. Cell Transplant 9 (2000) 701-704
46. Miki T., Mitamura K., Ross M.A., Stolz D.B., and Strom S.C. Identification of stem cell marker-positive cells by immunofluorescence in term human amnion. J Reprod Immunol 75 (2007) 91-96
47. Chan R.W., Schwab K.E., and Gargett C.E. Clonogenicity of human endometrial epithelial and stromal cells. Biol Reprod 70 (2004) 1738-1750
48. Trounson A., and Pera M. Human embryonic stem cells. Fertil Steril 76 (2001) 660-661
49. Tamagawa T., Ishiwata I., and Saito S. Establishment and characterization of a pluripotent stem cell line derived from human amniotic membranes and initiation of germ layers in vitro. Hum Cell 17 (2004) 125-130
50. Hitoshi S., Seaberg R.M., Koscik C., Alexson T., Kusunoki S., Kanazawa I., et al. Primitive neural stem cells from the mammalian epiblast differentiate to definitive neural stem cells under the control of notch signaling. Genes Dev 18 (2004) 1806-1811
51. Sakuragawa N., Thangavel R., Mizuguchi M., Hirasawa M., and Kamo I. Expression of markers for both neuronal and glial cells in human amniotic epithelial cells. Neurosci Lett 209 (1996) 9-12
52. Sakuragawa N., Misawa H., Ohsugi K., Kakishita K., Ishii T., Thangavel R., et al. Evidence for active acetylcholine metabolism in human amniotic epithelial cells: applicable to intracerebral allografting for neurologic disease. Neurosci Lett 232 (1997) 53-56
53. Elwan M.A., and Sakuragawa N. Evidence for synthesis and release of catecholamines by human amniotic epithelial cells. Neuroreport 8 (1997) 3435-3438
54. Kakishita K., Elwan M.A., Nakao N., Itakura T., and Sakuragawa N. Human amniotic epithelial cells produce dopamine and survive after implantation into the striatum of a rat model of Parkinson's disease: a potential source of donor for transplantation therapy. Exp Neurol 165 (2000) 27-34
55. Elwan M.A., Ishii T., and Sakuragawa N. Evidence of dopamine D1 receptor mRNA and binding sites in cultured human amniotic epithelial cells. Neurosci Lett 344 (2003) 157-160
56. Kakishita K., Nakao N., Sakuragawa N., and Itakura T. Implantation of human amniotic epithelial cells prevents the degeneration of nigral dopamine neurons in rats with 6-hydroxydopamine lesions. Brain Res 980 (2003) 48-56
57. Sankar V., and Muthusamy R. Role of human amniotic epithelial cell transplantation in spinal cord injury repair research. Neuroscience 118 (2003) 11-17
58. Bregman B.S., Broude E., McAtee M., and Kelley M.S. Transplants and neurotrophic factors prevent atrophy of mature CNS neurons after spinal cord injury. Exp Neurol 149 (1998) 13-27
59. Takashima S., Ise H., Zhao P., Akaike T., and Nikaido T. Human amniotic epithelial cells possess hepatocyte-like characteristics and functions. Cell Struct Funct 29 (2004) 73-84
60. Sakuragawa N., Enosawa S., Ishii T., Thangavel R., Tashiro T., Okuyama T., et al. Human amniotic epithelial cells are promising transgene carriers for allogeneic cell transplantation into liver. J Hum Genet 45 (2000) 171-176
61. Kosuga M., Takahashi S., Sasaki K., Enosawa S., Li X.K., Okuyama S., et al. Phenotype correction in murine mucopolysaccharidosis type VII by transplantation of human amniotic epithelial cells after adenovirus-mediated gene transfer. Cell Transplant 9 (2000) 687-692
62. Wei J.P., Zhang T.S., Kawa S., Aizawa T., Ota M., Akaike T., et al. Human amnion-isolated cells normalize blood glucose in streptozotocin-induced diabetic mice. Cell Transplant 12 (2003) 545-552
63. Bailo M., Soncini M., Vertua E., Signoroni P.B., Sanzone S., Lombardi G., et al. Engraftment potential of human amnion and chorion cells derived from term placenta. Transplantation 78 (2004) 1439-1448
64. Wolbank S., Peterbauer A., Fahrner M., Hennerbichler S., van Griensven M., Stadler G., et al. Dose-dependent immunomodulatory effect of human stem cells from amniotic membrane: a comparison with human mesenchymal stem cells from adipose tissue. Tissue Eng 13 (2007) 1173-1183
65. Avila M., Espana M., Moreno C., and Pena C. Reconstruction of ocular surface with heterologous limbal epithelium and amniotic membrane in a rabbit model. Cornea 20 (2001) 414-420
66. Yuge I., Takumi Y., Koyabu K., Hashimoto S., Takashima S., Fukuyama T., et al. Transplanted human amniotic epithelial cells express connexin 26 and Na-K-adenosine triphosphatase in the inner ear. Transplantation 77 (2004) 1452-1454
67. Kubo M., Sonoda Y., Muramatsu R., and Usui M. Immunogenicity of human amniotic membrane in experimental xenotransplantation. Invest Ophthalmol Vis Sci 42 (2001) 1539-1546
68. Meller D., Pires R.T., Mack R.J., Figueiredo F., Heiligenhaus A., Park W.C., et al. Amniotic membrane transplantation for acute chemical or thermal burns. Ophthalmology 107 (2000) 980-989
69. Tseng S.C., Prabhasawat P., Barton K., Gray T., and Meller D. Amniotic membrane transplantation with or without limbal allografts for corneal surface reconstruction in patients with limbal stem cell deficiency. Arch Ophthalmol 116 (1998) 431-441
70. Pires R.T., Chokshi A., and Tseng S.C. Amniotic membrane transplantation or conjunctival limbal autograft for limbal stem cell deficiency induced by 5-fluorouracil in glaucoma surgeries. Cornea 19 (2000) 284-287
71. Akle C.A., Adinolfi M., Welsh K.I., Leibowitz S., and McColl I. Immunogenicity of human amniotic epithelial cells after transplantation into volunteers. Lancet 2 (1981) 1003-1005
72. Sakuragawa N., Yoshikawa H., and Sasaki M. Amniotic tissue transplantation: clinical and biochemical evaluations for some lysosomal storage diseases. Brain Dev 14 (1992) 7-11
73. Hori J., Wang M., Kamiya K., Takahashi H., and Sakuragawa N. Immunological characteristics of amniotic epithelium. Cornea 25 (2006) S53-S58
74. Solomon A., Rosenblatt M., Monroy D., Ji Z., Pflugfelder S.C., and Tseng S.C. Suppression of interleukin 1alpha and interleukin 1beta in human limbal epithelial cells cultured on the amniotic membrane stromal matrix. Br J Ophthalmol 85 (2001) 444-449
75. Li H., Niederkorn J.Y., Neelam S., Mayhew E., Word R.A., McCulley J.P., et al. Immunosuppressive factors secreted by human amniotic epithelial cells. Invest Ophthalmol Vis Sci 46 (2005) 900-907
76. Shimazaki J., Aiba M., Goto E., Kato N., Shimmura S., and Tsubota K. Transplantation of human limbal epithelium cultivated on amniotic membrane for the treatment of severe ocular surface disorders. Ophthalmology 109 (2002) 1285-1290
77. Tseng S.C., Li D.Q., and Ma X. Suppression of transforming growth factor-beta isoforms, TGF-beta receptor type II, and myofibroblast differentiation in cultured human corneal and limbal fibroblasts by amniotic membrane matrix. J Cell Physiol 179 (1999) 325-335
78. Chajra H., Rousseau C.F., Cortial D., Ronziere M.C., Herbage D., Mallein-Gerin F., et al. Collagen-based biomaterials and cartilage engineering. Application to osteochondral defects. Biomed Mater Eng 18 (2008) S33-S45
79. Shi C., Zhu Y., Ran X., Wang M., Su Y., and Cheng T. Therapeutic potential of chitosan and its derivatives in regenerative medicine. J Surg Res 133 (2006) 185-192
80. Guan J., Ferrell N., James Lee L., and Hansford D.J. Fabrication of polymeric microparticles for drug delivery by soft lithography. Biomaterials 27 (2006) 4034-4041
81. Schmidt D., Mol A., Odermatt B., Neuenschwander S., Breymann C., Gossi M., et al. Engineering of biologically active living heart valve leaflets using human umbilical cord-derived progenitor cells. Tissue Eng 12 (2006) 3223-3232
82. Kaviani A., Guleserian K., Perry T.E., Jennings R.W., Ziegler M.M., and Fauza D.O. Fetal tissue engineering from amniotic fluid. J Am Coll Surg 196 (2003) 592-597
83. Kaviani A., Perry T.E., Dzakovic A., Jennings R.W., Ziegler M.M., and Fauza D.O. The amniotic fluid as a source of cells for fetal tissue engineering. J Pediatr Surg 36 (2001) 1662-1665
84. Kaviani A., Perry T.E., Barnes C.M., Oh J.T., Ziegler M.M., Fishman S.J., et al. The placenta as a cell source in fetal tissue engineering. J Pediatr Surg 37 (2002) 995-999
85. Fuchs J.R., Kaviani A., Oh J.T., LaVan D., Udagawa T., Jennings R.W., et al. Diaphragmatic reconstruction with autologous tendon engineered from mesenchymal amniocytes. J Pediatr Surg 39 (2004) 834-838
86. Kanczler J.M., Barry J., Ginty P., Howdle S.M., Shakesheff K.M., and Oreffo R.O. Supercritical carbon dioxide generated vascular endothelial growth factor encapsulated poly(d,l-lactic acid) scaffolds induce angiogenesis in vitro. Biochem Biophys Res Commun 352 (2007) 135-141
87. Carlson BM. Human embryology and developmental biology updated edition. Philadephia: Mosby; 2004. pp 59.
88. Moore KL, Persaud TVN. Before we are born: essentials of embryology and birth defects. Philadelphia: Saunders; 2003. pp 107.